HVAD: The ENDURANCE Supplemental Trial.

[1]  Alberto Aliseda,et al.  Impact of LVAD Implantation Site on Ventricular Blood Stagnation , 2017, ASAIO journal.

[2]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[3]  Valluvan Jeevanandam,et al.  Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.

[4]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[5]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[6]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[7]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  G. Ewald,et al.  The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. , 2015, JACC. Heart failure.

[9]  M. Slaughter,et al.  Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). , 2014, Journal of the American College of Cardiology.

[10]  Igor Gregoric,et al.  HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  Pranav Loyalka,et al.  Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation , 2012, Circulation.

[12]  M. Givertz,et al.  Mechanical Circulatory Support for Advanced Heart Failure: Patients and Technology in Evolution , 2012, Circulation.

[13]  G. Ewald,et al.  Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy , 2012, Circulation. Heart failure.

[14]  Daniel Tamez,et al.  Design concepts and principle of operation of the HeartWare ventricular assist system. , 2010, ASAIO journal.

[15]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[16]  P. Gorelick.  New horizons for stroke prevention: PROGRESS and HOPE , 2002, The Lancet Neurology.

[17]  A. Pavie,et al.  Mechanical Circulatory Support for Advanced Heart Failure: Effect of Patient Selection on Outcome , 2001, Circulation.

[18]  I S Chan,et al.  Test‐Based Exact Confidence Intervals for the Difference of Two Binomial Proportions , 1999, Biometrics.

[19]  R. Goeree,et al.  Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension. , 2016, Journal of the American Society of Hypertension : JASH.

[20]  Sean Pinney,et al.  Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  W. Holman.  Advances in Mechanical Circulatory Support Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) What Have We Learned and What Will We Learn? , 2012 .

[22]  ATS Statement , 2002 .